Shanghai Henlius Biotech (HKSE:02696) Short-Term Capital Lease Obligation : HK$69 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Henlius Biotech Short-Term Capital Lease Obligation?

Shanghai Henlius Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$69 Mil.

Shanghai Henlius Biotech's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (HK$95 Mil) to Jun. 2024 (HK$106 Mil) but then declined from Jun. 2024 (HK$106 Mil) to Dec. 2024 (HK$69 Mil).

Shanghai Henlius Biotech's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (HK$91 Mil) to Dec. 2023 (HK$95 Mil) but then declined from Dec. 2023 (HK$95 Mil) to Dec. 2024 (HK$69 Mil).

Shanghai Henlius Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Shanghai Henlius Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Henlius Biotech Short-Term Capital Lease Obligation Chart

Shanghai Henlius Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

85.40

90.84

90.95

95.12

69.37

Shanghai Henlius Biotech Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										90.95	89.04	95.12	105.90	69.37

Shanghai Henlius Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Shanghai Henlius Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shanghai Henlius Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Henlius Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Henlius Biotech Inc (HKSE:02696) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

B8 Building, No. 188 Yizhou Road, 11th Floor, Xuhui District, Shanghai, CHN, 200233

Website

https://www.henlius.com

Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China, Asia Pacific (excluding Mainland China), North America, South America, Oceania, and Europe. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.

Executives

Ubs Group Ag
Golden Valley Value Select Master Fund	2101 Beneficial owner
Vistra Trust (singapore) Pte. Limited	2301 Trustee
Lvc Sg Management Pte. Ltd.	2201 Interest of corporation controlled by you
Lvc Management Holdings Limited	2201 Interest of corporation controlled by you
Lin Lijun	2201 Interest of corporation controlled by you
Qatar Investment Authority	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun Industrial Co., Limited	2101 Beneficial owner
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Liu Scott Shi-kau	2201 Interest of corporation controlled by you

Shanghai Henlius Biotech Headlines

No Headlines